July Loan Agreement, dated July 5, 2023

Contract Categories: Business Finance - Loan Agreements
EX-10.2 5 ex10-2.htm

 

Exhibit 10.2

 

 

To: Mr. Josef Zelinger
CC: Dr Julian Kenyon
From: Mr. James Nathanielsz
Subject: Company Loan from Aggro Investments Pty Ltd to Propanc Biopharma Inc.

 

Dear Mr Zelinger,

 

The Board of Directors at Propanc Biopharma Inc. (“Propanc”) confirm acceptance and receipt of funds for the sum of two hundred and thirty thousand Australian dollars (AUD 230,000) from Aggro Investments Pty Ltd (“Aggro”) of 59 Seymour Road, Elsternwick, Victoria, Australia, 3185, of which you are Company Director.

 

The loan to Propanc is subject to the following terms & conditions:

Amount: A$230,000
Term: 3 years
Commencement date: 05 July 2023
Interest rate: 10% pa paid monthly in arrears
Debt warrant:

 

Warrant coverage: 100%
Amount shares of common stock: 15,000,000 (15 million)
Strike Price: USD 0.01 per share (US Dollars one penny)

 

A signed executed Common Stock Purchase Warrant is attached under Exhibit A.

 

Sincerely,  
   
/s/ James Nathanielsz  
James Nathanielsz  
Chief Executive Officer  
   
Approved by,  
   
/s/ Dr Julian Kenyon  
Dr Julian Kenyon  
Director  

 

p: +61 (0)3 9882 0780 a: 302/6 Butler Street, Camberwell, VIC 3124, AUSTRALIA w: www.propanc.com

 

1

 

 

Exhibit A: Propanc Common Stock Purchase Warrant to Aggro Investments Pty Ltd

 

2